NASDAQ: TLF

TANDY LEATHER FACTORY INC

CIK 0000909724 · SIC 3100 · Leather & Leather Products

Small Revenue $76M Assets $82M as of Nov 15, 2026

The following discussion, as well as other portions of this Form 10-K, contains forward-looking statements that reflect our plans, estimates and beliefs. Any such forward-looking statements (including, but not limited to, statements to the effect that Tandy Leather Factory, Inc. (“TLF”) or its… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (CNXC 10-Q) is open in full — no account needed.

8-K Filed Nov 10, 2026 · Period ending Nov 10, 2026

Summary not yet generated.

10-Q Filed Nov 10, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

Partner

Trade TLF commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Aug 11, 2026 · Period ending Aug 11, 2026

Summary not yet generated.

10-Q Filed Aug 11, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jun 10, 2026 · Period ending Jun 9, 2026

Summary not yet generated.

10-Q Filed May 11, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed May 11, 2026 · Period ending May 11, 2026

Summary not yet generated.

10-K/A Filed Mar 11, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Feb 24, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

8-K Filed Feb 24, 2026 · Period ending Feb 24, 2026

Summary not yet generated.

10-Q Filed Nov 10, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K Filed Feb 26, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 10, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(amounts in thousands, except share and per share data)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Net sales 18,522 17,264 56,218 54,072
Cost of sales 6,969 7,094 20,978 22,612
Gross profit 11,553 10,170 35,240 31,460
Operating expenses 10,997 10,848 33,777 31,811
Income (loss) from operations 556 (678) 1,463 (351)
Other income (expense):
Interest income 26 98 201 461
Gain on disposal of headquarters - 16,225
Other, net (7) (1,253) (100) (2,946)
Total other income (loss) 19 (1,155) 101 13,740
Income (loss) before income taxes 575 (1,833) 1,564 13,389
Income tax provision (benefit) 102 (481) 460 3,357
Net income (loss) 473 (1,352) 1,104 10,032
Foreign currency translation adjustments, net of tax 69 (235) (238) 70
Comprehensive income (loss) 542 (1,587) 866 10,102
Net income (loss) per common share:
Basic 0.06 (0.17) 0.14 1.20
Diluted 0.06 (0.17) 0.14 1.18
Weighted average number of shares outstanding:
Basic 8,192,075 8,142,441 8,150,039 8,378,083
Diluted 8,192,524 8,142,441 8,150,039 8,502,787

Condensed Consolidated Balance Sheets

(amounts in thousands, except share data and per share data)

Description September 30, 2026 (Unaudited) December 31, 2025
ASSETS
CURRENT ASSETS:
Cash and cash equivalents 5,727 16,087
Accounts receivable-trade, net of allowance for credit losses of $51 at September 30, 2026 and December 31, 2025 383 425
Inventory 37,509 33,238
Prepaid expenses 913 721
Other current assets 108 111
Total current assets 44,640 50,582
Property and equipment, at cost 27,603 26,203
Less accumulated depreciation (16,887) (15,978)
Property and equipment, net 10,716 10,225
Operating lease assets 25,497 24,736
Deferred income taxes 347 380
Other assets 731 710
TOTAL ASSETS 81,931 86,633
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable-trade 2,090 2,154
Accrued expenses and other liabilities 3,375 3,704
Income taxes payable 92 428
Current portion of operating lease liabilities 3,960 3,512
Total current liabilities 9,517 9,798
Uncertain tax positions 227 227
Other non-current liabilities 148 149
Operating lease liabilities, non-current 24,522 23,868
COMMITMENTS AND CONTINGENCIES (Note 7)
STOCKHOLDERS’ EQUITY:
Common stock, $0.0024 par value; 15,000,000 shares authorized; 9,616,451 and 9,497,251 shares issued at September 30, 2026 and December 31, 2025, respectively; 8,192,075 and 8,072,875 shares outstanding at September 30, 2026 and December 31, 2025, respectively 22 22
Paid-in capital 3,766 3,651
Retained earnings 55,892 60,843
Treasury stock at cost (1,424,376 shares at September 30, 2026 and December 31, 2025) (9,773) (9,773)
Accumulated other comprehensive loss, net of tax (2,390) (2,152)
Total stockholders’ equity 47,517 52,591
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 81,931 86,633

Condensed Consolidated Statements of Cash Flows

(amounts in thousands)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Cash flows from operating activities:
Net income 1,104 10,032
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization 853 609
Operating lease asset amortization 4,061 3,915
Gain on disposal of assets - (16,225)
Stock-based compensation 253 338
Deferred income taxes 32 1,043
Changes in operating assets and liabilities:
Accounts receivable-trade 40 30
Inventory (4,474) (191)
Prepaid expenses (192) (186)
Other current assets 3 12
Accounts payable-trade (63) (815)
Accrued expenses and other liabilities (325) (897)
Income taxes, net (335) 716
Other assets (23) (190)
Operating lease liabilities (3,722) (3,727)
Total adjustments (3,892) (15,568)
Net cash used in operating activities (2,788) (5,536)
Cash flows from investing activities:
Purchase of property and equipment (1,351) (6,590)
Proceeds from sales of Headquarter assets, net - 24,897
Net cash provided by (used in) investing activities (1,351) 18,307
Cash flows from financing activities:
Dividend Paid (6,055) (12,745)
Withholding of vested stock for employee tax (137) (1,470)
Net cash used in financing activities (6,192) (14,215)
Effect of exchange rate changes on cash and cash equivalents (29) 191
Net decrease in cash and cash equivalents (10,360) (1,253)
Cash and cash equivalents, beginning of period 16,087 13,271
Cash and cash equivalents, end of period 5,727 12,018

Amounts as printed on the EDGAR/iXBRL face — (amounts in thousands, except share and per share data); (amounts in thousands, except share data and per share data); (amounts in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About TANDY LEATHER FACTORY INC

Source: Item 1 (Business) from the 10-K filed February 24, 2026. Description as filed by the company with the SEC.

ITEM 1.

BUSINESS

The following discussion, as well as other portions of this Form 10-K, contains forward-looking statements that reflect our plans, estimates and beliefs. Any such forward-looking statements
(including, but not limited to, statements to the effect that Tandy Leather Factory, Inc. (“TLF”) or its management “anticipates,” “plans,” “estimates,” “expects,” “believes,” “intends,” and other similar expressions) that are not statements of
historical fact should be considered forward-looking statements and should be read in conjunction with our Consolidated Financial Statements and related notes contained elsewhere in this report. These forward-looking statements are made based upon
management’s current plans, expectations, estimates, assumptions and beliefs concerning future events impacting us and should be read carefully because they involve risks and uncertainties. We assume no obligation to update or otherwise revise these
forward-looking statements, except as required by law. Specific examples of forward-looking statements include, but are not limited to, statements regarding our forecasts of financial performance, share repurchases, store openings or store closings,
capital expenditures and working capital requirements. Our actual results could materially differ from those discussed in such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to,
those discussed below and elsewhere in this F

Read full description ↓

orm 10-K and particularly in “